Systemic and inhaled fluoroquinolone antibiotics – reminder on restrictions of use
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Active substance |
Fluoroquinolones
|
| Therapeutic area (MeSH) |
Anti-Bacterial Agents
|
| Procedure number |
SC01/EMA/2018/29/PE
|
| Regulatory outcome |
Variation
|
| DHPC type |
Post-authorisation measure
|
| Referral name |
Quinolone- and fluoroquinolone-containing medicinal products
|
| Dissemination date |
08/06/2023
|